Erasmus School of Health Policy & Management
Assistant professor | Health Technology Assessment (HTA)
- leeneman@eshpm.eur.nl
More information
Work
- Saskia de Groot, Hedwig M. Blommestein, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Pieter H.M. van Baal (2025) - Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma Opent extern - Medical Decision Making, 45 (3), 302-317 - doi: 10.1177/0272989X251319338Opent extern - [link]Opent extern
- Hedwig M. Blommestein, Saskia de Groot, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Margreet G. Franken (2025) - Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model Opent extern - European Journal of Cancer, 218 - doi: 10.1016/j.ejca.2024.115071Opent extern - [link]Opent extern
- N. S.H. Xander, B. Leeneman, A. M.C. Dingemans, W. E. Fiets, W. K. de Jong, N. E.M. Uyl, A. N.M. Wymenga, A. K.L. Reyners & C. A. Uyl-de Groot (2024) - Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not? Opent extern - European Journal of Cancer, 209 - doi: 10.1016/j.ejca.2024.114262Opent extern - [link]Opent extern
- Olivier J. van Not, Alfons J.M. van den Eertwegh, Hilde Jalving, Manja Bloem, John B. Haanen, Rozemarijn S. van Rijn, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Jan Willem de Groot J W B, Geke A.P. Hospers, Ellen Kapiteijn, Brenda Leeneman, Piersma D, Marion Stevense-den Boer, Astrid A.M. van der Veldt, Gerard Vreugdenhil G, Michel W.J.M. Wouters, Willeke A.M. Blokx & Karijn P.M. Suijkerbuijk (2024) - Long-Term Survival in Patients With Advanced Melanoma Opent extern - JAMA network open, 7 (8) - doi: 10.1001/jamanetworkopen.2024.26641Opent extern - [link]Opent extern
- Brenda Leeneman, Nicolas S.H. Xander, W. Edward Fiets, Wouter K. de Jong, Nathalie E.M. Uyl, A. N.Machteld Wymenga, An K.L. Reyners & Carin A. Uyl-de Groot (2024) - Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness Opent extern - European Journal of Cancer, 202 - doi: 10.1016/j.ejca.2024.114002Opent extern - [link]Opent extern
- Brenda Leeneman, Hedwig M. Blommestein, Annemieke van Dongen-Leunis, Mattia Algeri, Willem E. Fibbe, Liesbeth Oosten, Carin A. Uyl-de Groot & Frederick W. Thielen (2023) - Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease Opent extern - European Journal of Haematology, 111 (2), 240-246 - doi: 10.1111/ejh.13987Opent extern - [link]Opent extern
- M. G. Franken, B. Leeneman, M. J.B. Aarts, A. C.J. van Akkooi, F. W.P.J. van den Berkmortel, M. J. Boers-Sonderen, A. J.M. van den Eertwegh, J. W.B. de Groot, G. A.P. Hospers, E. Kapiteijn, D. Piersma, R. S. van Rijn, K. P.M. Suijkerbuijk, A. A.M. van der Veldt, H. M. Westgeest, M. W.J.M. Wouters, J. B.A.G. Haanen & C. A. Uyl-de Groot (2021) - Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs Opent extern - ESMO Open, 6 (6) - doi: 10.1016/j.esmoop.2021.100320Opent extern - [link]Opent extern
- Brenda Leeneman (2021) - Evidence-based decision making on drug reimbursement in melanoma: Using real-world evidence to complement evidence from randomized controlled trials Opent extern
- Brenda Leeneman, Kay Schreuder, Carin A. Uyl - de Groot, Alexander C.J. van Akkooi, John B.A.G. Haanen, Marlies Wakkee, Margreet G. Franken & Marieke W.J. Louwman (2021) - Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): A nationwide population-based study Opent extern - European Journal of Cancer, 2021 (154), 111-119 - doi: 10.1016/j.ejca.2021.06.007Opent extern - [link]Opent extern
- Brenda Leeneman, Hedwig M. Blommestein, Veerle M.H. Coupé, Mathijs P. Hendriks, Wim H.J. Kruit, Peter W. Plaisier, Serge Van Ruth, Albert J. Ten Tije, Michel W.J.M. Wouters, Margreet G. Franken & Carin A. Uyl-De Groot (2021) - Real-world healthcare costs of localized and regionally advanced cutaneous melanoma in the Netherlands Opent extern - Melanoma Research, 31 (3), 249-257 - doi: 10.1097/cmr.0000000000000732Opent extern - [link]Opent extern
Health Technology AssessmentOpent extern
- Year Level
- master, master, master
- Year
- 2024
- Course Code
- GW4546M
AfstudeerprojectOpent extern
- Level
- bachelor 3
- Year Level
- bachelor 3
- Year
- 2024
- Course Code
- GW312
Master Thesis HEPLOpent extern
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4555M
Master Thesis HEOpent extern
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4592M
AfstudeerprojectOpent extern
- Level
- bachelor 3
- Year Level
- bachelor 3
- Year
- 2024
- Course Code
- GW311